UBS Group’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.17M | Buy |
1,370,461
+1,187,334
| +648% | +$2M | ﹤0.01% | 4897 |
|
|
2025
Q4 | $306K | Sell |
183,127
-24,953
| -12% | -$43.2K | ﹤0.01% | 6354 |
|
|
2025
Q3 | $352K | Sell |
208,080
-19,520
| -9% | -$23.1K | ﹤0.01% | 6335 |
|
|
2025
Q2 | $206K | Sell |
227,600
-36,317
| -14% | -$21.5K | ﹤0.01% | 6700 |
|
|
2025
Q1 | $119K | Buy |
263,917
+43,029
| +19% | +$25.2K | ﹤0.01% | 6906 |
|
|
2024
Q4 | $111K | Buy |
220,888
+49,457
| +29% | +$36.3K | ﹤0.01% | 6806 |
|
|
2024
Q3 | $155K | Buy |
171,431
+94,965
| +124% | +$88K | ﹤0.01% | 6053 |
|
|
2024
Q2 | $76.2K | Sell |
76,466
-63,606
| -45% | -$70.3K | ﹤0.01% | 6363 |
|
|
2024
Q1 | $207K | Sell |
140,072
-4,455
| -3% | -$5.05K | ﹤0.01% | 5832 |
|
|
2023
Q4 | $158K | Buy |
144,527
+91,556
| +173% | +$100K | ﹤0.01% | 5918 |
|
|
2023
Q3 | $62.5K | Sell |
52,971
-8,066
| -13% | -$11K | ﹤0.01% | 6156 |
|
|
2023
Q2 | $86.1K | Buy |
61,037
+57,784
| +1,776% | +$79.9K | ﹤0.01% | 6133 |
|
|
2023
Q1 | $4.88K | Sell |
3,253
-7,253
| -69% | -$10.1K | ﹤0.01% | 8129 |
|
|
2022
Q4 | $12.3K | Buy |
10,506
+9,204
| +707% | +$11.6K | ﹤0.01% | 8292 |
|
|
2022
Q3 | $1K | Sell |
1,302
-10,118
| -89% | -$14.9K | ﹤0.01% | 9979 |
|
|
2022
Q2 | $18K | Buy |
11,420
+10,526
| +1,177% | +$13.9K | ﹤0.01% | 7016 |
|
|
2022
Q1 | $1K | Sell |
894
-39,038
| -98% | -$60.6K | ﹤0.01% | 9885 |
|
|
2021
Q4 | $97K | Sell |
39,932
-167,770
| -81% | -$393K | ﹤0.01% | 6342 |
|
|
2021
Q3 | $523K | Buy |
207,702
+203,156
| +4,469% | +$521K | ﹤0.01% | 4705 |
|
|
2021
Q2 | $13K | Sell |
4,546
-2,791
| -38% | -$7.22K | ﹤0.01% | 7788 |
|
|
2021
Q1 | $17K | Sell |
7,337
-17,265
| -70% | -$41.5K | ﹤0.01% | 7520 |
|
|
2020
Q4 | $44K | Buy |
24,602
+23,483
| +2,099% | +$32.8K | ﹤0.01% | 6299 |
|
|
2020
Q3 | $1K | Sell |
1,119
-238
| -18% | -$210 | ﹤0.01% | 7797 |
|
|
2020
Q2 | $1K | Sell |
1,357
-69,559
| -98% | -$61.2K | ﹤0.01% | 7771 |
|
|
2020
Q1 | $59K | Sell |
70,916
-84,997
| -55% | -$84.6K | ﹤0.01% | 5690 |
|
|
2019
Q4 | $139K | Buy |
155,913
+72,340
| +87% | +$60.3K | ﹤0.01% | 5827 |
|
|
2019
Q3 | $82K | Buy |
83,573
+59,781
| +251% | +$61.9K | ﹤0.01% | 5880 |
|
|
2019
Q2 | $26K | Buy |
23,792
+11,894
| +100% | +$13.7K | ﹤0.01% | 6440 |
|
|
2019
Q1 | $15K | Sell |
11,898
-42,804
| -78% | -$53.2K | ﹤0.01% | 6542 |
|
|
2018
Q4 | $49K | Sell |
54,702
-24,348
| -31% | -$37.3K | ﹤0.01% | 6105 |
|
|
2018
Q3 | $162K | Buy |
79,050
+47,046
| +147% | +$98.8K | ﹤0.01% | 5219 |
|
|
2018
Q2 | $58K | Buy |
32,004
+14,859
| +87% | +$29.9K | ﹤0.01% | 5862 |
|
|
2018
Q1 | $40K | Buy |
17,145
+7,502
| +78% | +$17.6K | ﹤0.01% | 5882 |
|
|
2017
Q4 | $18K | Buy |
9,643
+9,243
| +2,311% | +$20.2K | ﹤0.01% | 6628 |
|
|
2017
Q3 | $1K | Sell |
400
-481
| -55% | -$1.19K | ﹤0.01% | 7574 |
|
|
2017
Q2 | $2K | Buy |
881
+481
| +120% | +$1.34K | ﹤0.01% | 7379 |
|
|
2017
Q1 | $1K | Sell |
400
-8,382
| -95% | -$23.8K | ﹤0.01% | 7428 |
|
|
2016
Q4 | $27K | Buy |
8,782
+6,808
| +345% | +$20.9K | ﹤0.01% | 6313 |
|
|
2016
Q3 | $7K | Buy |
1,974
+25
| +1% | +$69 | ﹤0.01% | 6981 |
|
|
2016
Q2 | $4K | Sell |
1,949
-960
| -33% | -$2.35K | ﹤0.01% | 7231 |
|
|
2016
Q1 | $7K | Sell |
2,909
-2,653
| -48% | -$5.92K | ﹤0.01% | 6856 |
|
|
2015
Q4 | $18K | Buy |
5,562
+2,409
| +76% | +$7.2K | ﹤0.01% | 6857 |
|
|
2015
Q3 | $8K | Buy |
3,153
+1,349
| +75% | +$3.49K | ﹤0.01% | 7409 |
|
|
2015
Q2 | $6K | Sell |
1,804
-1,349
| -43% | -$5.23K | ﹤0.01% | 7787 |
|
|
2015
Q1 | $13K | Sell |
3,153
-3,328
| -51% | -$11.5K | ﹤0.01% | 7428 |
|
|
2014
Q4 | $19K | Buy |
+6,481
| New | +$17.5K | ﹤0.01% | 7737 |
|
Other funds holding LCTX
BC
VCM
DC
RA
AC
